Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal RNA processing protein 9 (RRP9) is a highly conserved, nucleolar, WD-repeat protein that specifically associates with U3 small nucleolar RNA (snoRNA), forming part of the U3 snoRNP complex, which is essential for eukaryotic ribosome biogenesis[1][2][4]. RRP9 plays a key role in the early steps of precursor ribosomal RNA (pre-rRNA) processing by facilitating the cleavage events necessary for the formation of the 18S rRNA—a component of the small ribosomal subunit[1][2][3][4]. Structurally, RRP9 has a WD-repeat domain, forming a β-propeller fold involved in specific RNA and protein interactions[1][2]. RRP9 functions as a molecular scaffold in the SSU (small subunit) processome, where it specifically recognizes and binds to the U3 snoRNA via conserved motifs (notably a unique B/C box)[1][2]. Its precise association with U3 snoRNA, enhanced by interaction with the Snu13 protein, is critical for correct assembly of the U3 snoRNP complex and subsequent pre-rRNA processing[1][2][3]. Mutations in RRP9 or in U3 snoRNA disrupting this interaction lead to failure in ribosome assembly and—at least in yeast—cell lethality[1][2][3]. There is currently no evidence indicating that RRP9 is a therapeutic target, nor are there known drugs or small molecules targeting this protein. Consequently, no clinical safety concerns, mechanism-of-action details, or approved biomarkers are associated with RRP9 in a therapeutic context.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal RNA processing protein 9 (RRP9).